Rapid ferric carboxymaltose infusion (Ferinject) for iron deficiency anaemia in Aboriginal children: a randomised controlled trial

快速输注羧基麦芽糖铁（Ferinject）治疗原住民儿童缺铁性贫血：一项随机对照试验

• 批准号: nhmrc : 1120234
• 负责人: A/Pr Gurmeet Singh
• 金额: $ 84.53万
• 依托单位: Menzies School of Health Research
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/rapid-ferric-carboxymaltose-controlled-trial/946462
• 关键词: Rapid; ferric; carboxymaltose; infusion; Ferinject

The “Rapid Iron Infusion Project” will assess whether an intravenous infusion of ferric carboxymaltose (Ferinject) given over 15 minutes in children prior to their discharge from hospital will reduce the risk of ongoing anaemia. The potential benefits of iron infusion include higher haemoglobin levels, fewer painful iron injections over the next 6-9 months, better adherence to recommended treatment, and less use of primary health care resources.

“快速铁注入项目”将评估在儿童出院前15分钟内静脉注入羧基麦芽糖铁（Ferinject）是否会降低持续贫血的风险。铁输注的潜在益处包括更高的血红蛋白水平，在接下来的6-9个月内减少痛苦的铁注射，更好地坚持推荐的治疗，以及更少地使用初级卫生保健资源。